Subscribe to Genomics/Proteomics

The Lead

PDI Announces Launch of NGS Test for Cancer Risk Assessment

December 17, 2014 12:07 pm | News | Comments

PDI, Inc. announced that its molecular diagnostics subsidiary, Interpace Diagnostics, has launched its new next-generation sequencing (NGS) ThyGenX test to assist physicians in distinguishing between benign and malignant genotypes in indeterminate thyroid nodules.  Read more...

Predicting Antibiotic Resistance

December 17, 2014 10:14 am | News | Comments

Treating bacterial infections with antibiotics is becoming increasingly difficult as bacteria...

Drug Class Shows Promising Results for Breast Cancer Therapy

December 11, 2014 11:53 am | News | Comments

A new class of drugs could help overcome resistance to standard treatments. Read more... ...

Supplement May Lower CVD Risk in People of Low Birth Weight

December 10, 2014 9:07 am | by University of Cambridge | News | Comments

A simple supplement could be a safe and cost-effective way of reducing heart disease in...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Genetic Errors Linked to Aging Can Make Leukemia Appear After Treatment

December 9, 2014 1:23 pm | by Caroline Arbanas, Washington University in St. Louis | News | Comments

Treatment aimed at curing cancer can lead to a form of leukemia with a poor prognosis. Read more...                          

Vaccine May Prevent Antibiotic Resistant Skin Infections

December 9, 2014 1:15 pm | News | Comments

Treatment is difficult because MRSA is resistant to many antibiotics, and the infections can recur, placing family members and other close contacts at risk of infection. Read more....             

New Agent Shrinks Small Cell Lung Tumors in Pre-Clinical Testing

December 8, 2014 1:20 pm | News | Comments

Researchers found that a new agent can disable the basic part of a tumor cell's survival mechanism. Read more...                         


New Immunotherapy Breakthrough Discovered

December 8, 2014 1:06 pm | by Robert Levy, Harvard Medical School | News | Comments

A therapy that liberates the immune system to attack cancer cells drove Hodgkin lymphoma into complete or partial remission. Read more...                     

Study Suggests Potential Therapy for Common Form of Dementia

December 5, 2014 12:56 pm | by Bob Shepard, University of Alabama at Birmingham | News | Comments

Drugs that boost the function of a specific type of neurotransmitter receptor may provide benefit to patients with the second most common type of dementia. Read more...                

Genetic Errors Linked to More ALS Cases Than Previously Thought

December 5, 2014 12:43 pm | by Michael C. Purdy, Washington University in St. Louis | News | Comments

Genetic mutations may cause more cases of ALS than scientists previously had realized. Read more...                          

Resistance and Futility

December 5, 2014 12:25 pm | by Elizabeth Cooney, Harvard Medical School | News | Comments

New findings reveal how penicillin deals bacteria a devastating blow. Read more...                              

Building Personalized Approaches to Patient Care

December 5, 2014 9:43 am | by Jonathan Sheldon, PhD, global vice president, Oracle Health Sciences | Articles | Comments

With the evolution of electronic medical records (EMR) systems, and the integration of genomic data with multi-dimensional longitudinal clinical data, the opportunity is rife to build truly personalized approaches to patient care. 


Retina Discovery Could Lead to New Cancer Treatments

December 5, 2014 9:19 am | by University of Adelaide | News | Comments

Eye surgeons have discovered that the retina in human eyes uses energy in a very similar way to cancer. Read more...                        

MS Research Finds First Evidence of Rogue Protein

December 3, 2014 12:43 pm | News | Comments

The Surrey-led research, published in the journal Frontiers in Neurology, has identified a rogue protein in multiple sclerosis that attacks the body's central nervous system. Read more...                                                  

Tailor-Made Pharmaceuticals As Basis for Novel Antidepressants

December 2, 2014 12:42 pm | by Max Planck Institute | News | Comments

Scientists at the Max Planck Institute of Psychiatry in Munich have now developed the first potent and highly selective inhibitor for stress-related psychiatric disorders. Read more...             

A Hybrid Vehicle That Delivers DNA

November 26, 2014 12:00 pm | News | Comments

A new hybrid vehicle is under development. Its performance isn’t measured by the distance it travels, but rather the delivery of its cargo: vaccines that contain genetically engineered DNA to fight HIV, cancer, influenza and other maladies. Read more...

Protein Key to Development of Blood Stem Cells Identified

November 25, 2014 12:13 pm | by Peter Bracke, UCLA | News | Comments

Understanding the self-replication mechanisms is critical for improving stem cell therapies for blood-related diseases and cancers. Read more...                                           


$1B Alliance Between Menarini, Oxford BioTherapeutics for Enhanced AML Treatment

November 25, 2014 10:04 am | News | Comments

This is the first of five development programs between the two companies to enter the clinic in a $1 billion strategic oncology alliance. Read more...                   

Vascular Solutions Gets Clearance for Tumor Treating Gel-Block

November 25, 2014 9:44 am | News | Comments

Vascular Solutions gets clearance from the FDA for tumor treating gel blocks. Read more...                             

Genetic Test Unlocks Cause of Brisbane Boy's Rare Disease

November 25, 2014 9:24 am | News | Comments

Queensland researchers have led an international effort to uncover the gene behind a young Brisbane boy’s rare developmental condition. Read more...                   

Exciting Gains in Fighting Breast Cancer Hormone-Therapy Resistance

November 25, 2014 8:55 am | by Cynthia Fox, Science Editor | Articles | Comments

Guided by breakthrough research on the Estrogen Receptor 1 (ESR1) gene, many researchers and pharmaceutical companies are in hot pursuit of the next big anti-resistance breast cancer drug. Read more...                 

Virus Discovery Could Impact HIV Drug Research

November 20, 2014 12:23 pm | News | Comments

A research team has unlocked the structure of an unusual virus that lives in volcanic hot springs. Read more...                         

New Laser Therapy Helps Slow Macular Degeneration

November 19, 2014 9:36 am | News | Comments

This new faster laser did not result in damage to the retina. Read more...                               

New Insight Into Cells Could Lead to Better Drugs

November 19, 2014 9:11 am | News | Comments

Researchers investigated how different types of immune cells communicate with each other – and how they kill cancerous or infected cells. Read more...                   

Method Developed for Detecting Tumor-Causing Mutations in Saliva

November 17, 2014 1:18 pm | News | Comments

Current methods to screen for lung cancer mutations in plasma or blood are complicated, technique-dependent and not readily available. Read more...                   

Statins Reverse Learning Disabilities Caused By Genetic Disorder

November 17, 2014 1:08 pm | News | Comments

Scientists have discovered that statins reverse the learning disabilities caused by a genetic disorder. Read more...                        

A New Approach to Fighting Leukemia

November 17, 2014 9:50 am | News | Comments

Leukemia treatments are often limited by the fact that the cancer cells can adapt to resist drugs. Read more...                         

New Insight Into Common Cause of Blindness

November 14, 2014 10:44 am | News | Comments

Scientists identified an important new factor behind one of the major causes of blindness. Read more...                           

DNA 'Blind Spots' May Hide Cancer Causing Mistakes

November 14, 2014 9:27 am | News | Comments

Scientists have found more than 400 ‘blind spots’ in DNA which could hide cancer-causing gene faults. Read more...                         

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.